AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-7.31%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$226M
AUM Growth
+$226M
(-11%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$12.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$111M
| $109M | 48.42% | 6,300,773 | – | – |
|
2
Annexon
ANNX
$226M
| $54.4M | 24.08% | 1,954,978 | – | – |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $23.8M | 10.51% | 16,609,449 +9,000,000 | +118% | +$12.9M |
|
4
Akebia Therapeutics
AKBA
$833M
| $15.7M | 6.97% | 4,652,561 | – | – |
|
5
Assembly Biosciences
ASMB
$190M
| $10.2M | 4.53% | 2,227,500 | – | – |
|
|
WHWK
6
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $7.25M | 3.21% | 5,621,835 | – | – |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.15M | 2.28% | 126,270 | – | – |
|